ArticleJOM (Warrendale, Pa. : 1989)2024
An Investigation on the Effect of Contrast Agents in the Chitosan-Nanoclay Shear Thinning Hydrogel for Trans-Catheter Arterial Embolization.
Article in JOM (Warrendale, Pa. : 1989), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Tantalum-Based Nanomaterials: From Properties to Biomedical Applications.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- A multi-modal embolic gel system for long-term fluorescence imaging and photothermal therapy.Biomaterials advances · 2025Article
- Image-guided embolization using Ta@Ca-Alg microspheres with optimized mechanical performance.Biomaterials science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Shear thinning hydrogels are emerging as a potential candidate of embolic agents for minimally invasive transcatheter arterial embolization because of their advantages over the commonly used conventional solid and liquid embolic agents. The transformation from solid to liquid and vice versa on the application and removal of shear force enables the shear thinning hydrogels to successfully occlude vasculatures of any diameters and thus can be used for the treatment of diseased or injured vasculature, including vascular malformation and malignant or benign tumors. Imageability of the embolic gel is of paramount importance as for successful occlusion of vasculatures requires real-time monitoring of the deployment of the embolic agents. Here, we studied the effect of different contrast agents, including iohexol, Omnipaque
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.